Intraperitoneal injection of ART in a xenograft model of human CML KMB-5 cells resulted in a significant suppression of tumor progression and suppression of phosphorylation of p38/ERK/STAT5/CREB in ART-treated tumor tissues. The gene discussed is STAT5A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.